I am a breastfeeding mother and i want to know if it is safe to use UNII-4NW20GFQ7H? Is UNII-4NW20GFQ7H safe for nursing mother and child? Does UNII-4NW20GFQ7H extracts into breast milk? Does UNII-4NW20GFQ7H has any long term or short term side effects on infants? Can UNII-4NW20GFQ7H influence milk supply or can UNII-4NW20GFQ7H decrease milk supply in lactating mothers?
Information in this record refers to the use of UNII-4NW20GFQ7H (I 123 ortho-iodohippurate; I 123 OIH) as a kidney function diagnostic agent. The United States Nuclear Regulatory Commission states that breastfeeding need not be interrupted after administration of I 123 OIH in doses up to 100 MBq (4 mCi) to a nursing mother.[1] However, some experts recommend nursing the infant just before administration of the radiopharmaceutical and interrupting breastfeeding for 8 to 12 hours after the dose.[2][3] If the mother has expressed and saved milk prior to the examination, she can feed it to the infant during the period of nursing interruption.[2][4][5] Mothers need not refrain from close contact with their infants after usual clinical doses.[6] Mothers concerned about the level of radioactivity in their milk could ask to have it tested at a nuclear medicine facility at their hospital. When the radioactivity is at a safe level she may resume breastfeeding. A method for measuring milk radioactivity and determining the time when a mother can safely resume breastfeeding has been published.[7]
Disclaimer:
Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. We do not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.